Amarin partners with Neopharm to commercialise Vazkepa tablets in Israel
Neopharm will be appointed as Amarin’s sole and exclusive distributor to import, register, distribute, and commercialise Vazkepa in…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
09 Aug 23
Neopharm will be appointed as Amarin’s sole and exclusive distributor to import, register, distribute, and commercialise Vazkepa in…
09 Aug 23
Under the investment, SK bioscience will acquire a 7% stake or 6.5 million shares of Novavax’s common stock…
09 Aug 23
The company is planning to cut operations at its Canton, Massachusetts, facility and Rockville, Maryland factory and lay…
09 Aug 23
The cardiovascular outcomes trial evaluated subcutaneous once-weekly semaglutide 2.4mg against placebo as an adjunct to the standard of…
09 Aug 23
The clinical trial comes after the company's Trial-Ready Screening Cohort Study conducted in 2022, which involved screening, enrolling,…
09 Aug 23
The goal of the collaboration is to identify small molecule candidates with activity towards a tumour suppressor protein…
09 Aug 23
FDA-approved generic for MRI procedures is fully substitutable for Gadavist
08 Aug 23
BioNTech will obtain rights to commercialise the DB-1305 worldwide, except in Mainland China, Hong Kong Special Administrative Region…
08 Aug 23
According to the terms of the agreement, Astellas will invest $25m to buy 8,333,333 shares of common stock…
08 Aug 23
Under the terms of the agreement, Nautic will acquire Tabula Rasa for $10.50 in cash per share and…
PharmaceuticalsConsulting, Training and Other Pharmaceutical Services